Investors are betting on a cancer cure with these stocks - CNBC

CNBC
Investors are betting on a cancer cure with these stocks
CNBC
The U.S. Food and Drug Administration this week approved a Novartis drug as the first ever drug using a new form of cancer treatment called CAR-T cell therapy. Analysts also point to pricing power and potential for acquisition as reasons why they like ...

and more »

(Source: Market News via Google News)